The Potential Rise in the Price of DiaMedica Therapeutics Inc (DMAC) following insiders activity
DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $2.03 million on Aug 25 ’25. In the deal valued at $6.00 per share,338,265 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 7,654,045 shares worth roughly $52.2 million. Then, STAHLBERG JAN bought 293,601 shares, […]
DiaMedica Therapeutics Inc [DMAC] Stock bought by Insider STAHLBERG JAN for $2.03 million
DiaMedica Therapeutics Inc’s recent filing unveils that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $2.03 million on Aug 25 ’25. In the deal valued at $6.00 per share,338,265 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 7,654,045 shares worth roughly $47.0 million. Then, STAHLBERG JAN bought 293,601 […]
DMAC’s latest rating updates from top analysts.
DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $5.4 million on Jul 23 ’25. In the deal valued at $3.50 per share,1,542,857 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 6,764,465 shares worth roughly $38.63 million. Then, Von Koch Thomas bought 2,857,142 […]
H.C. Wainwright gives a Buy recommendation for DiaMedica Therapeutics Inc (DMAC)
DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $5.4 million on Jul 23 ’25. In the deal valued at $3.50 per share,1,542,857 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 6,764,465 shares worth roughly $35.31 million. Then, Von Koch Thomas bought 2,857,142 […]
DiaMedica Therapeutics Inc [NASDAQ: DMAC] Sees Increase in Stock Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. DiaMedica Therapeutics Inc shares valued at $5,400,000 were purchased by STAHLBERG JAN on Jul 23 ’25. At $3.50 per share, STAHLBERG JAN acquired 1,542,857 shares. The insider’s holdings grew to 6,764,465 shares worth approximately […]
Understanding the Risks of Investing in DiaMedica Therapeutics Inc (DMAC)
DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $5.4 million on Jul 23 ’25. In the deal valued at $3.50 per share,1,542,857 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 6,764,465 shares worth roughly $30.37 million. Then, Von Koch Thomas bought 2,857,142 […]